LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 5 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 2. - Dataset (ID:20313)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 68.70 | 19.50 | 4077 | 5743 | 0.7172 | 0.8692 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 70.70 | 19.50 | 4028 | 5784 | 0.7012 | 0.8569 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 72.60 | 19.50 | 4169 | 5854 | 0.7147 | 0.8647 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 74.60 | 19.50 | 4177 | 5927 | 0.7068 | 0.8569 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 76.60 | 19.50 | 4150 | 5898 | 0.7046 | 0.8535 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 78.50 | 19.50 | 4097 | 5949 | 0.6898 | 0.8475 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 80.50 | 19.50 | 4021 | 6018 | 0.6690 | 0.8364 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 82.50 | 19.50 | 3936 | 6031 | 0.6533 | 0.8143 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 84.40 | 19.50 | 3848 | 6038 | 0.6378 | 0.7911 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 86.40 | 19.50 | 3813 | 6081 | 0.6275 | 0.7612 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 88.40 | 19.50 | 3745 | 6064 | 0.6176 | 0.7404 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 90.40 | 19.50 | 3756 | 6097 | 0.6161 | 0.7125 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 92.30 | 19.50 | 3743 | 6153 | 0.6082 | 0.6780 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 94.30 | 19.50 | 3744 | 6154 | 0.6080 | 0.6436 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 2.70 | 19.50 | 238 | 163 | 1.4741 | 0.6098 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 4.60 | 19.50 | 368 | 295 | 1.2610 | 0.4965 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.60 | 19.50 | 441 | 390 | 1.1289 | 0.4566 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.60 | 19.50 | 487 | 442 | 1.1009 | 0.4762 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.60 | 19.50 | 517 | 467 | 1.1066 | 0.4893 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.50 | 19.50 | 544 | 495 | 1.0977 | 0.4808 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.50 | 19.50 | 574 | 537 | 1.0691 | 0.5066 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.50 | 19.50 | 633 | 626 | 1.0103 | 0.4562 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.40 | 19.50 | 734 | 775 | 0.9464 | 0.5545 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.40 | 19.50 | 831 | 951 | 0.8753 | 0.5470 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.40 | 19.50 | 946 | 1150 | 0.8242 | 0.5476 |